{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T10:55:35Z","timestamp":1791024935799,"version":"4.1.0"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ejpb.2026.115217","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:10:32Z","timestamp":1787065832000},"page":"115217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Towards macrophage-oriented Antituberculosis therapy: nanohydrogel and liposomal delivery of rifampicin\u2013berberine Co-nanocrystals for enhanced intracellular Antituberculosis activity"],"prefix":"10.1016","volume":"228","author":[{"given":"Xiaoguo","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengwei","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouhua","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengbin","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim Oluwatobi","family":"Kehinde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3759-7141","authenticated-orcid":false,"given":"Nontobeko E.","family":"Mvubu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud E.S.","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7694-924X","authenticated-orcid":false,"given":"Zhongfa","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ejpb.2026.115217_b0005","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.tim.2018.02.012","article-title":"Mycobacterium tuberculosis","volume":"26","author":"Koch","year":"2018","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.ejpb.2026.115217_b0010","doi-asserted-by":"crossref","unstructured":"G. T. Mashabela, T. J. de Wet, and D. F. Warner, \u201cMycobacterium tuberculosis Metabolism,\u201d Microbiol. Spectr., vol. 7, no. 4, Jul. 2019, doi: 10.1128\/microbiolspec.GPP3-0067-2019.","DOI":"10.1128\/microbiolspec.GPP3-0067-2019"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115217_b0015","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1016\/S2666-5247(22)00359-7","article-title":"WHO\u2019s Global Tuberculosis Report 2022","volume":"4","author":"Bagcchi","year":"2023","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.ejpb.2026.115217_b0020","article-title":"Multidrug-Resistant TB (MDR-TB) and Extensively Drug-Resistant TB (XDR-TB) among Children: where we stand now","author":"Chowdhury","year":"2023","journal-title":"Cureus"},{"issue":"12","key":"10.1016\/j.ejpb.2026.115217_b0025","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nrmicro2236","article-title":"The spectrum of latent tuberculosis: rethinking the biology and intervention strategies","volume":"7","author":"Barry","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2026.115217_b0030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1574-6968.1994.tb07194.x","article-title":"Mycobacterial cell wall: Structure and role in natural resistance to antibiotics","volume":"123","author":"Jarlier","year":"1994","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.ejpb.2026.115217_b0035","doi-asserted-by":"crossref","unstructured":"M. Shamaei and M. Mirsaeidi, \u201cNontuberculous Mycobacteria, Macrophages, and Host Innate Immune Response,\u201d Infect. Immun., vol. 89, no. 8, Jul. 2021, doi: 10.1128\/IAI.00812-20.","DOI":"10.1128\/IAI.00812-20"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115217_b0040","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1128\/AAC.46.2.267-274.2002","article-title":"Evolution of Drug Resistance in Mycobacterium tuberculosis\u00a0: Clinical and Molecular Perspective","volume":"46","author":"Gillespie","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115217_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2022.102410","article-title":"The impact of diabetes mellitus on the pharmacokinetics of rifampicin among tuberculosis patients: a systematic review and meta-analysis study","volume":"16","author":"Metwally","year":"2022","journal-title":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews"},{"key":"10.1016\/j.ejpb.2026.115217_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2019.103937","article-title":"Evolution of rifampicin treatment for tuberculosis","volume":"74","author":"Grobbelaar","year":"2019","journal-title":"Infect. Genet. Evol."},{"issue":"5","key":"10.1016\/j.ejpb.2026.115217_b0055","first-page":"357","article-title":"Nanotechnology based drug delivery system(s) for the management of tuberculosis","volume":"44","author":"Pandey","year":"2006","journal-title":"Indian J. Exp. Biol."},{"issue":"8","key":"10.1016\/j.ejpb.2026.115217_b0060","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.2217\/nnm.11.122","article-title":"Liposomes as Drug delivery Systems for the Treatment of TB","volume":"6","author":"Pinheiro","year":"2011","journal-title":"Nanomedicine"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115217_b0065","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4103\/2230-973X.96920","article-title":"Drug delivery systems: an updated review","volume":"2","author":"Tiwari","year":"2012","journal-title":"Int. J. Pharm. Investig."},{"issue":"12","key":"10.1016\/j.ejpb.2026.115217_b0070","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1166\/jbn.2021.3201","article-title":"Nano-Drug delivery Systems: possible end to the rising Threats of Tuberculosis","volume":"17","author":"Sheikh","year":"2021","journal-title":"J. Biomed. Nanotechnol."},{"issue":"669","key":"10.1016\/j.ejpb.2026.115217_b0075","doi-asserted-by":"crossref","first-page":"Nov","DOI":"10.1126\/scitranslmed.abj1270","article-title":"Targeting cancer glycosylation repolarizes tumor-associated macrophages allowing effective immune checkpoint blockade","volume":"14","author":"Stanczak","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejpb.2026.115217_b0080","first-page":"27","article-title":"\u201cBerberine and its Role in","author":"Cicero","year":"2016","journal-title":"Chronic Disease\u201d"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115217_b0085","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/03602532.2017.1306544","article-title":"The metabolism of berberine and its contribution to the pharmacological effects","volume":"49","author":"Wang","year":"2017","journal-title":"Drug Metab. Rev."},{"issue":"S2","key":"10.1016\/j.ejpb.2026.115217_b0090","first-page":"20","article-title":"Berberine: a Traditional Natural Product with Novel Biological Activities","volume":"26","author":"Hou","year":"2020","journal-title":"Altern. Ther. Health Med."},{"issue":"14","key":"10.1016\/j.ejpb.2026.115217_b0095","doi-asserted-by":"crossref","first-page":"9389","DOI":"10.1039\/C8CP00124C","article-title":"Understanding the co-loading and releasing of doxorubicin and paclitaxel using chitosan functionalized single-walled carbon nanotubes by molecular dynamics simulations","volume":"20","author":"Karnati","year":"2018","journal-title":"PCCP"},{"issue":"4","key":"10.1016\/j.ejpb.2026.115217_b0100","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2174\/1567201817666200220121306","article-title":"Encapsulating Rifampicin into SLNs: a Viable Option for Managing its Bioavailability Issues upon Co-delivery with Isoniazid","volume":"17","author":"Singh","year":"2020","journal-title":"Curr. Drug Deliv."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115217_b0105","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1080\/10837450.2019.1671864","article-title":"Preparation of ursolic acid\u2013phospholipid complex by solvent-assisted grinding method to improve dissolution and oral bioavailability","volume":"25","author":"Wang","year":"2020","journal-title":"Pharm. Dev. Technol."},{"issue":"9\u201310","key":"10.1016\/j.ejpb.2026.115217_b0110","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.drudis.2008.03.004","article-title":"The role of cocrystals in pharmaceutical science","volume":"13","author":"Shan","year":"2008","journal-title":"Drug Discov. Today"},{"issue":"3","key":"10.1016\/j.ejpb.2026.115217_b0115","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1039\/B815174A","article-title":"The role of solvent in mechanochemical and sonochemical cocrystal formation: a solubility-based approach for predicting cocrystallisation outcome","volume":"11","author":"Fri\u0161\u010di\u0107","year":"2009","journal-title":"CrstEngComm"},{"issue":"32","key":"10.1016\/j.ejpb.2026.115217_b0120","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.2174\/1381612822666160726111253","article-title":"Mechanochemical Approaches to Pharmaceutical Cocrystal Formation and Stability Analysis","volume":"22","author":"Lin","year":"2016","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115217_b0125","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.xphs.2021.06.024","article-title":"Dry and Wet Mechanochemical Synthesis of Piroxicam and Saccharin Co-Crystals and Evaluation by Powder X-Ray Diffraction, thermal Analysis and Mid- and Near- Infrared Spectroscopy","volume":"111","author":"Otsuka","year":"2022","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115217_b0130","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jpba.2014.07.011","article-title":"Solid-state NMR studies of theophylline co-crystals with dicarboxylic acids","volume":"100","author":"Pindelska","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejpb.2026.115217_b0135","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ssnmr.2014.11.002","article-title":"NMR crystallography of ezetimibe co-crystals","volume":"65","author":"L\u00fcdeker","year":"2015","journal-title":"Solid State Nucl. Magn. Reson."},{"key":"10.1016\/j.ejpb.2026.115217_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120246","article-title":"Determination of co-crystal phase purity by mid infrared spectroscopy and multiple curve resolution","volume":"595","author":"Queiroz","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115217_b0145","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/polym12010005","article-title":"Application of Differential Scanning Calorimetry (DSC) and Modulated Differential Scanning Calorimetry (MDSC) in Food and Drug Industries","volume":"12","author":"Leyva-Porras","year":"2019","journal-title":"Polymers (basel)"},{"issue":"9","key":"10.1016\/j.ejpb.2026.115217_b0150","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.3390\/cells10092177","article-title":"A Universal Approach to Analyzing Transmission Electron Microscopy with ImageJ","volume":"10","author":"Lam","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ejpb.2026.115217_b0155","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.colsurfb.2017.03.044","article-title":"Rifampicin loaded chitosan nanoparticle dry powder presents an improved therapeutic approach for alveolar tuberculosis","volume":"154","author":"Rawal","year":"2017","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ejpb.2026.115217_b0160","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ejps.2018.08.038","article-title":"Chitosan nanoparticles as a promising approach for pulmonary delivery of bedaquiline","volume":"124","author":"Rawal","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"issue":"12","key":"10.1016\/j.ejpb.2026.115217_b0165","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1016\/j.xphs.2023.09.015","article-title":"Investigating the Correlation between Drug Physical Properties and Physical Characteristics and Drug Entrapment Efficiencies of Chitosan-TPP Nanoparticles","volume":"112","author":"Jaradat","year":"2023","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115217_b0170","doi-asserted-by":"crossref","unstructured":"F. Yan et al., \u201cNanohydrogel of Curcumin\/Berberine Co\u2010Crystals Induces Apoptosis via Dual Covalent\/Noncovalent Inhibition of Caspases in Endometrial Cancer Cell Lines: The Synergy Between Pharmacokinetics and Pharmacodynamics,\u201d Journal of Molecular Recognition, vol. 38, no. 2, Mar. 2025, doi: 10.1002\/jmr.70004.","DOI":"10.1002\/jmr.70004"},{"issue":"11","key":"10.1016\/j.ejpb.2026.115217_b0175","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.3390\/pharmaceutics17111459","article-title":"Advanced Nanosystems and Emerging Therapies: Innovations in Tuberculosis Treatment and Drug Resistance","volume":"17","author":"Sharma","year":"2025","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115217_b0180","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2174\/1872213X09666150929105501","article-title":"Formulation of Nanoparticles against TB - a Review","volume":"9","author":"Kataria","year":"2016","journal-title":"Recent Pat. Inflamm. Allergy Drug Discov."},{"issue":"5","key":"10.1016\/j.ejpb.2026.115217_b0185","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1080\/14737159.2020.1740596","article-title":"An evaluation of liposome-based diagnostics of pulmonary and extrapulmonary tuberculosis","volume":"20","author":"Tandel","year":"2020","journal-title":"Expert Rev. Mol. Diagn."},{"issue":"17","key":"10.1016\/j.ejpb.2026.115217_b0190","doi-asserted-by":"crossref","first-page":"9337","DOI":"10.3390\/ijms25179337","article-title":"Liposomal Formulations of Metallodrugs for Cancer Therapy","volume":"25","author":"Botter","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejpb.2026.115217_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.125250","article-title":"Chitosan-based hydrogel wound dressing: from mechanism to applications, a review","volume":"244","author":"Zhao","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"issue":"12","key":"10.1016\/j.ejpb.2026.115217_b0200","doi-asserted-by":"crossref","first-page":"5354","DOI":"10.1039\/D3MH00717K","article-title":"Dynamic light scattering and transmission electron microscopy in drug delivery: a roadmap for correct characterization of nanoparticles and interpretation of results","volume":"10","author":"Filippov","year":"2023","journal-title":"Mater. Horiz."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115217_b0205","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1248\/yakushi.18-00171-1","article-title":"Nanosize Particle Analysis by Dynamic Light Scattering (DLS)","volume":"139","author":"Ashizawa","year":"2019","journal-title":"Yakugaku Zasshi"},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2026.115217_b0210","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ijpharm.2018.06.025","article-title":"Visual validation of the measurement of entrapment efficiency of drug nanocarriers","volume":"547","author":"Lv","year":"2018","journal-title":"Int. J. Pharm."},{"issue":"12","key":"10.1016\/j.ejpb.2026.115217_b0215","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/s41434-021-00265-7","article-title":"Chitosan-coated Zn-metal-organic framework nanocomposites for effective targeted delivery of LNA-antisense miR-224 to colon tumor: in vitro studies","volume":"29","author":"Mokri","year":"2022","journal-title":"Gene Ther."},{"key":"10.1016\/j.ejpb.2026.115217_b0220","doi-asserted-by":"crossref","unstructured":"P. Jayachandran et al., \u201cGreen Synthesized Silver Nanoparticle-Loaded Liposome-Based Nanoarchitectonics for Cancer Management: In Vitro Drug Release Analysis,\u201d Biomedicines, vol. 11, no. 1, p. 217, Jan. 2023, doi: 10.3390\/biomedicines11010217.","DOI":"10.3390\/biomedicines11010217"},{"issue":"3","key":"10.1016\/j.ejpb.2026.115217_b0225","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2174\/1567201812666150209143731","article-title":"Current Approaches for in vitro Drug Release Study of Long Acting Parenteral Formulations","volume":"12","author":"Dadhaniya","year":"2015","journal-title":"Curr. Drug Deliv."},{"issue":"16","key":"10.1016\/j.ejpb.2026.115217_b0230","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.3390\/polym16162368","article-title":"Oral Administration of Berberine Hydrochloride Based on Chitosan\/Carboxymethyl-\u03b2-Cyclodextrin Hydrogel","volume":"16","author":"Clemence","year":"2024","journal-title":"Polymers (basel)"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115217_b0235","first-page":"Nov","article-title":"Genetic Manipulation of Mycobacterium tuberculosis","volume":"6","author":"Larsen","year":"2007","journal-title":"Curr. Protoc. Microbiol."},{"issue":"5","key":"10.1016\/j.ejpb.2026.115217_b0240","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1021\/cg3002948","article-title":"Polymorphs, Salts, and Cocrystals: What\u2019s in a name?","volume":"12","author":"Aitipamula","year":"2012","journal-title":"Cryst. Growth Des."},{"issue":"6","key":"10.1016\/j.ejpb.2026.115217_b0245","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1021\/cg900129f","article-title":"Pharmaceutical Cocrystals and their Physicochemical Properties","volume":"9","author":"Schultheiss","year":"2009","journal-title":"Cryst. Growth Des."},{"issue":"3","key":"10.1016\/j.ejpb.2026.115217_b0250","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1021\/mp0601345","article-title":"The Salt\u2212Cocrystal Continuum: the Influence of Crystal Structure on Ionization State","volume":"4","author":"Childs","year":"2007","journal-title":"Mol. Pharm."},{"issue":"27","key":"10.1016\/j.ejpb.2026.115217_b0255","doi-asserted-by":"crossref","first-page":"9952","DOI":"10.1021\/ja403264c","article-title":"Crystal Engineering: from Molecule to Crystal","volume":"135","author":"Desiraju","year":"2013","journal-title":"J. Am. Chem. Soc."},{"issue":"7","key":"10.1016\/j.ejpb.2026.115217_b0260","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.addr.2007.05.011","article-title":"Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates","volume":"59","author":"Blagden","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115217_b0265","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nrd1632","article-title":"Recent advances with liposomes as pharmaceutical carriers","volume":"4","author":"Torchilin","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejpb.2026.115217_b0270","doi-asserted-by":"crossref","unstructured":"G. Bozzuto and A. Molinari, \u201cLiposomes as nanomedical devices,\u201d Int. J. Nanomedicine, p. 975, Feb. 2015, doi: 10.2147\/IJN.S68861.","DOI":"10.2147\/IJN.S68861"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115217_b0275","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1556-276X-8-102","article-title":"Liposome: classification, preparation, and applications","volume":"8","author":"Akbarzadeh","year":"2013","journal-title":"Nanoscale Res. Lett."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115217_b0280","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jconrel.2004.08.010","article-title":"Recent advances on chitosan-based micro- and nanoparticles in drug delivery","volume":"100","author":"Agnihotri","year":"2004","journal-title":"J. Control. Release"},{"issue":"7","key":"10.1016\/j.ejpb.2026.115217_b0285","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.progpolymsci.2006.06.001","article-title":"Chitin and chitosan: Properties and applications","volume":"31","author":"Rinaudo","year":"2006","journal-title":"Prog. Polym. Sci."},{"issue":"5","key":"10.1016\/j.ejpb.2026.115217_b0290","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.3390\/md8051567","article-title":"Application of Spectroscopic Methods for Structural Analysis of Chitin and Chitosan","volume":"8","author":"Kumirska","year":"2010","journal-title":"Mar. Drugs"},{"issue":"9","key":"10.1016\/j.ejpb.2026.115217_b0295","doi-asserted-by":"crossref","first-page":"Sep","DOI":"10.1002\/ejlt.201800039","article-title":"Comparative Effects of Cholesterol and \u03b2\u2010Sitosterol on the Liposome Membrane Characteristics","volume":"120","author":"Jovanovi\u0107","year":"2018","journal-title":"Eur. J. Lipid Sci. Technol."},{"issue":"8","key":"10.1016\/j.ejpb.2026.115217_b0300","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.progpolymsci.2011.02.001","article-title":"Chitosan\u2014A versatile semi-synthetic polymer in biomedical applications","volume":"36","author":"Dash","year":"2011","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.ejpb.2026.115217_b0305","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2015.00286","article-title":"Advances and challenges of Liposome Assisted Drug delivery","volume":"6","author":"Sercombe","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejpb.2026.115217_b0310","unstructured":"A. N. . Martin, P. J. . Sinko, and Yashveer. Singh, Martin\u2019s physical pharmacy and pharmaceutical sciences\u00a0: physical chemical and biopharmaceutical principles in the pharmaceutical sciences, 6th Edition. Lippincott Williams & Wilkins, 2011."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115217_b0315","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0939-6411(03)00161-9","article-title":"Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications","volume":"57","author":"Berger","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115217_b0320","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1146\/annurev-physiol-012110-142317","article-title":"Lysosomal Acidification Mechanisms","volume":"74","author":"Mindell","year":"2012","journal-title":"Annu. Rev. Physiol."},{"issue":"3","key":"10.1016\/j.ejpb.2026.115217_b0325","first-page":"297","article-title":"Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential","volume":"1","author":"Immordino","year":"2006","journal-title":"Int. J. Nanomedicine"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115217_b0330","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0939-6411(00)00090-4","article-title":"Hydrogels in pharmaceutical formulations","volume":"50","author":"Peppas","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2026.115217_b0335","series-title":"Polymorphism in pharmaceutical solids","author":"Brittain","year":"2019"},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2026.115217_b0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tca.2011.03.034","article-title":"ICTAC Kinetics Committee recommendations for performing kinetic computations on thermal analysis data","volume":"520","author":"Vyazovkin","year":"2011","journal-title":"Thermochim Acta"},{"key":"10.1016\/j.ejpb.2026.115217_b0345","first-page":"187","article-title":"\u201cNanotechnology-based Drug Repurposing for the Treatment of Tuberculosis,\u201d in Therapeutics of Mycobacterium","author":"Pal","year":"2026","journal-title":"Singapore: Springer Nature Singapore"},{"issue":"3","key":"10.1016\/j.ejpb.2026.115217_b0350","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ejpb.2012.04.007","article-title":"Chitosan-based drug delivery systems","volume":"81","author":"Bernkop-Schn\u00fcrch","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2026.115217_b0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2010.03.017","article-title":"Formulation strategy and use of excipients in pulmonary drug delivery","volume":"392","author":"Pilcer","year":"2010","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.ejpb.2026.115217_b0360","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1046\/j.1365-2125.2003.01892.x","article-title":"Pulmonary drug delivery. Part I: Physiological factors affecting therapeutic effectiveness of aerosolized medications","volume":"56","author":"Labiris","year":"2003","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejpb.2026.115217_b9000","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/370938","article-title":"Development of Oral Sustained Release Rifampicin Loaded Chitosan Nanoparticles by Design of Experiment","volume":"2013","author":"Patel","year":"2013","journal-title":"J. Drug Deliv."},{"issue":"12","key":"10.1016\/j.ejpb.2026.115217_b9005","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.jsps.2020.10.008","article-title":"Mannose receptor targeted bioadhesive chitosan nanoparticles of clofazimine for effective therapy of tuberculosis","volume":"28","author":"Pawde","year":"2020","journal-title":"Saudi Pharmaceutical Journal"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115217_b9010","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1186\/s12951-023-02156-y","article-title":"Advanced drug delivery and therapeutic strategies for tuberculosis treatment","volume":"21","author":"Nair","year":"2023","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.ejpb.2026.115217_b9015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jciso.2023.100095","article-title":"Micro and nano-carriers-based pulmonary drug delivery system: Their current updates, challenges, and limitations \u2013 A review","volume":"12","author":"Kumar","year":"2023","journal-title":"JCIS Open"},{"issue":"9","key":"10.1016\/j.ejpb.2026.115217_b9020","first-page":"Sep","article-title":"Nanocarrier-Based Systems for Targeted Delivery: Current Challenges and Future Directions","volume":"6","author":"Xu","year":"2025","journal-title":"MedComm (Beijing)"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126002389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126002389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T10:48:50Z","timestamp":1791024530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641126002389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":77,"alternative-id":["S0939641126002389"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115217","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Towards macrophage-oriented Antituberculosis therapy: nanohydrogel and liposomal delivery of rifampicin\u2013berberine Co-nanocrystals for enhanced intracellular Antituberculosis activity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115217","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115217"}}